X
API Suppliers
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
0
Listed Suppliers
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
https://www.fiercepharma.com/pharma/merck-bayer-drug-s-trial-win-for-entresto-competitor-could-actually-be-a-boon-for-novartis
https://www.prnewswire.com/news-releases/novartis-paragon-hf-analyses-suggest-entresto-benefit-beyond-hfref-300959592.html
https://www.fiercepharma.com/pharma/merck-bayer-drug-s-trial-win-for-entresto-competitor-could-actually-be-a-boon-for-novartis
https://www.fiercepharma.com/pharma/merck-bayer-drug-s-trial-win-for-entresto-competitor-could-actually-be-a-boon-for-novartis
https://www.fiercepharma.com/manufacturing/idt-biologika-opens-vaccine-manufacturing-facility-germany
http://www.pmlive.com/pharma_news/novartis_heart_failure_drug_entresto_fails_to_impress,_could_limit_growth_1295471
https://www.fiercepharma.com/pharma/zolgensma-launch-track-and-fully-line-expectation-says-novartis-ceo
https://www.fiercepharma.com/marketing/abbvie-humira-pfizer-lyrica-steady-at-top-february-ad-chart-but-see-new-entrant-ibrance
https://www.in-pharmatechnologist.com/Article/2018/03/12/Renewed-interest-in-understudied-co-crystals-to-drive-better-meds-says-scientist
https://endpts.com/big-day-looming-novartis-new-ceo-vas-narasimhan-readies-his-jump-into-a-marketing-melee/
http://www.pmlive.com/pharma_news/alcons_return_to_growth_gives_novartis_options,_says_ceo_1198743
http://www.fiercepharma.com/financials/novartis-notches-q2-earnings-surprise-despite-generic-price-erosion
https://www.globaldata.com/heart-failure-market-surpass-16-billion-2026-novartis-drug-entresto-triggers-huge-growth/
http://www.pmlive.com/pharma_news/new_drugs_cant_keep_novartis_sales_on_the_up_1191795
http://www.fiercepharma.com/marketing/serelaxin-s-demise-ups-stakes-novartis-latest-entresto-boosting-moves
http://www.fiercepharma.com/marketing/acc-skinny-amgen-s-pcsk9-outcry-az-s-sglt2-death-cuts-xarelto-s-aspirin-beat
http://www.fiercepharma.com/marketing/novartis-heart-failure-med-entresto-cuts-blood-sugar-staves-off-insulin-starts-diabetics
http://www.fiercebiotech.com/biotech/ironwood-s-colonic-delivery-platform-a-pipeline-within-a-pipeline-say-analysts
http://www.fiercepharma.com/pharma/novartis-sees-weak-q4-and-year-and-expects-a-repeat-putting-alcon-unit-s-future-question
http://www.medpagetoday.com/Cardiology/CardioBrief/62163
http://www.fiercepharma.com/pharma/under-drug-cost-attack-big-pharma-ceos-raise-value-based-pricing-flag
http://www.fiercepharma.com/pharma/novartis-slows-gleevec-bleeding-to-manage-q3-beats-amid-alcon-s-downward-spiral
http://www.fiercepharma.com/pharma/merck-aetna-set-up-januvia-pay-for-performance-plan
http://www.fiercepharma.com/marketing/how-can-novartis-get-more-docs-entresto-bandwagon-esc-experts-have-some-ideas
https://www.statnews.com/pharmalot/2016/06/27/harvard-pilgrim-eli-lilly-novartis/
http://www.prnewswire.com/news-releases/timely-use-of-novartis-entresto-could-prevent-or-postpone-over-28000-us-deaths-per-year-among-hfref-patients-according-to-an-expert-analysis-in-jama-cardiology-300288694.html
http://www.biopharmadive.com/news/why-new-data-may-reverse-the-slow-start-of-novartis-new-heart-med/421149/?
http://www.reuters.com/article/us-novartis-heart-drug-idUSKCN0YG13G
http://www.reuters.com/article/us-novartis-entresto-idUSKCN0YA1YH
https://www.statnews.com/pharmalot/2016/05/17/novartis-oncology-cancer/
http://www.fiercepharma.com/pharma/cigna-inks-results-based-deals-pricey-amgen-sanofi-pcsk9-meds
http://www.pharmatimes.com/Article/16-04-27/NICE_backs_restricted_use_of_heart_drug_Entresto.aspx
http://www.reuters.com/article/us-novartis-roche-idUSKCN0XM0QC
http://www.fiercepharma.com/marketing/novartis-ceo-racehorse-drug-launch-over-us
http://www.reuters.com/article/us-health-heart-drug-idUSKCN0XI0T6
http://www.reuters.com/article/us-novartis-entresto-meeting-idUSKCN0WZ0FY
http://www.fiercepharma.com/story/acc-latest-lilly-merck-pfizer-novartis-and-more-unveil-key-data/2016-04-04
http://www.fiercepharmamarketing.com/story/analyst-slashes-entresto-sales-forecast-half-skeptical-heart-docs-hobble-up/2016-03-23
http://www.fiercepharma.com/story/novartis-ceo-jimenez-sees-pay-drop-119m-alcon-emerging-markets-shortfalls/2016-03-22
http://www.pharmatimes.com/Article/16-03-20/NICE_confirms_support_for_Novartis_heart_drug_Entresto.aspx
http://www.forbes.com/sites/matthewherper/2016/03/08/former-fda-official-calls-for-tougher-restrictions-on-obesity-drug-contrave/?ss=pharma-healthcare#62221af27c88
http://www.reuters.com/article/us-cigna-novartis-drugpricing-idUSKCN0VH25K
http://www.biospace.com/News/three-drugs-could-catapult-three-big-pharma/408029/source=TopBreaking
http://www.fiercepharma.com/story/doctors-pounce-alarmist-horrifying-novartis-heart-failure-ad/2016-02-08
http://www.reuters.com/article/us-novartis-results-insurers-idUSKCN0V527F
http://www.fiercepharmamarketing.com/story/novartis-retrains-entresto-reps-plans-field-force-expansion-payers-finally/2016-01-28
http://www.fiercepharma.com/story/novartis-divvies-troubled-alcon-targets-1b-cuts-rd-and-manufacturing-rejig/2016-01-27
Market Place
Share 
